BAY 2416964 manufacturers
- BAY 2416964
-
- $40.00
-
2026-09-15
- CAS:2242464-44-2
- Purity: 99.73%
- Supply Ability: 10g
- BAY 2416964
-
- $40.00
-
2026-08-16
- CAS:2242464-44-2
- Purity: 99.73%
- Supply Ability: 10g
- BAY 2416964
-
- $40.00
-
2026-07-14
- CAS:2242464-44-2
- Purity: 99.73%
- Supply Ability: 10g
|
| Product Name: | BAY 2416964 | | Synonyms: | AHR antagonist 3;(S)-6-(4-chlorophenyl)-N-(1-hydroxypropan-2-yl)-2-(1-methyl-1H-pyrazol-4-yl)-3-oxo-2,3-dihydropyridazine-4-carboxamide;4-Pyridazinecarboxamide, 6-(4-chlorophenyl)-2,3-dihydro-N-[(1S)-2-hydroxy-1-methylethyl]-2-(1-methyl-1H-pyrazol-4-yl)-3-oxo-;6-(4-chlorophenyl)-N-[(2S)-1-hydroxypropan-2-yl]-2-(1-methylpyrazol-4-yl)-3-oxopyridazine-4-carboxamide;BAY 2416964 USP/EP/BP;BAY241696;BAY 2416964, 10 mM in DMSO | | CAS: | 2242464-44-2 | | MF: | C18H18ClN5O3 | | MW: | 387.82 | | EINECS: | | | Product Categories: | | | Mol File: | 2242464-44-2.mol |  |
| | BAY 2416964 Chemical Properties |
| density | 1.42±0.1 g/cm3(Predicted) | | solubility | DMSO:64.0(Max Conc. mg/mL);165.02(Max Conc. mM) | | pka | 11.81±0.20(Predicted) | | form | Solid | | color | Light yellow to green yellow | | InChI | InChI=1S/C18H18ClN5O3/c1-11(10-25)21-17(26)15-7-16(12-3-5-13(19)6-4-12)22-24(18(15)27)14-8-20-23(2)9-14/h3-9,11,25H,10H2,1-2H3,(H,21,26)/t11-/m0/s1 | | InChIKey | YAGSZKAJPHGVOV-NSHDSACASA-N | | SMILES | C1(=O)N(C2=CN(C)N=C2)N=C(C2=CC=C(Cl)C=C2)C=C1C(N[C@@H](C)CO)=O |
| | BAY 2416964 Usage And Synthesis |
| Use | BAY 2416964 (compound 192) is a potent and orally active antagonist of aryl hydrocarbon receptor (AhR) with IC50 of 341 nM. BAY 2416964 has the potential in the treatment of solid tumors. | | In vitro | BAY 2416964 (Example 192) induces AHR-regulated gene CYP1A1 expression with IC50 of 4.30 nM in a human monocytic U937 cells.
| | In vivo | BAY 2416964 (Example 192) is dissolved in Ethanol/Solutol/Water (10/40/50) and given at 30 mg/kg, QD, p.o.. The efficacy is calculated based on tumor volume. BAY 2416964 (Example 192) is shown to have the potential for solid tumour treatment.
| | Uses | BAY 2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1, example 192, has an IC50 of 341 nM. BAY 2416964 has the potential for solid tumors treatment[1]. | | References | [1] Ilona GUTCHER, et al. 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer. WO2018146010A1 |
| | BAY 2416964 Preparation Products And Raw materials |
|